Skip Navigation

European Journal of Heart Failure 2008 10(8):725-732; doi:10.1016/j.ejheart.2008.06.002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chandrasekaran, B.
Right arrow Articles by McDonagh, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandrasekaran, B.
Right arrow Articles by McDonagh, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 European Society of Cardiology

The role of apelin in cardiovascular function and heart failure

Badrinathan Chandrasekaran*, Owais Dar and Theresa McDonagh

Imperial college, Royal Brompton Hospital campus Sydney St, London SW3 6NP, United Kingdom

* Corresponding author. Tel.: +44 2073588121x8178. E-mail address: b.chandrasekaran{at}ic.ac.uk (B. Chandrasekaran).


  Abstract

Apelin is a novel peptide that acts through the APJ receptor, sharing similarities with the angiotensin II–angiotensin II type 1 receptor pathway. It is a peripheral vasodilator, powerful inotrope and may affect central fluid homeostasis. Animal and human studies suggest that it may play a role in the pathogenesis of heart failure by modulating the harmful effects of angiotensin II. Apelin is reduced in patients with heart failure and up regulated following favourable left ventricular remodelling. It is widely distributed in a number of tissues, mainly restricted to vascular endothelium. This comprehensive review of the literature highlights the important studies that have led to the discovery of apelin and its role in cardiovascular function and heart failure.

Key Words: Apelin • APJ • Heart failure

Received November 30, 2007; Revised April 21, 2008; Accepted June 4, 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J EndocrinolHome page
D. E Henley, F. Buchanan, R. Gibson, J. A Douthwaite, S. A Wood, W. W Woltersdorf, J. R Catterall, and S. L Lightman
Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy
J. Endocrinol., October 1, 2009; 203(1): 181 - 188.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
P. M. Pilowsky, M. S. Y. Lung, D. Spirovski, and S. McMullan
Differential regulation of the central neural cardiorespiratory system by metabotropic neurotransmitters
Phil Trans R Soc B, September 12, 2009; 364(1529): 2537 - 2552.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. Moore-Morris, A. Varrault, M. E. Mangoni, A. Le Digarcher, V. Negre, C. Dantec, L. Journot, J. Nargeot, and B. Couette
Identification of Potential Pharmacological Targets by Analysis of the Comprehensive G Protein-Coupled Receptor Repertoire in the Four Cardiac Chambers
Mol. Pharmacol., May 1, 2009; 75(5): 1108 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 ESC Textbook of Cardiovascular MedicineHome page
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner
CHAPTER 23 Heart Failure
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.